13-valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6-17 years of age with sickle cell disease previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study.
Pediatr Blood Cancer
; 62(8): 1427-36, 2015 Aug.
Article
en En
| MEDLINE
| ID: mdl-25810327
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Vacunas Conjugadas
/
Vacunas Neumococicas
/
Anemia de Células Falciformes
/
Anticuerpos Antibacterianos
Tipo de estudio:
Clinical_trials
Límite:
Adolescent
/
Child
/
Female
/
Humans
/
Male
Idioma:
En
Año:
2015
Tipo del documento:
Article